Immudyne Retires 1.136 Million Shares - Planning Additional Purchases

Florence, Kentucky. September 29, 2011. Immudyne, Inc. (Pink Sheets: IMMD) a leading industry provider of all-natural products for immune system support from yeast beta-glucan, is pleased to announce the retirement of 1,136,842 shares of the Company’s common stock purchased in a recent private transaction. Mark McLaughlin, CEO of Immudyne stated, “The retiring of these shares is part of ongoing efforts to enhance the value of our long-term shareholders’ ownership in Immudyne. With only 24.5 million shares currently outstanding, and virtually no company debt, our capital structure accommodates future growth both organically and through strategic opportunities.”

2011-09-21 14:01

Immudyne Taps Industry Veteran As Director Of Product Development

Florence, Kentucky, September 21, 2011. Immudyne, Inc. (Pink Sheets: IMMD) the world's leading research and production firm specializing in immune system support compounds based on Beta Glucan derived from baker's yeast, announced today that it has appointed Jim Roufs as Director of Product Development. Mr. Roufs brings more than twenty years of industry experience in the dietary supplement field to augment Immudyne's research and production team. He previously led New Product Development for more than seven years for the world's largest dietary supplement brand, where he participated in developing and launching numerous products with multimillion dollar annual revenues. Mr. Roufs activities will be focused on food and beverage applications for Immudyne's premier Beta Glucan product, as well as dietary supplements for immune system support and athlete training aids.

ImmuDyne Share

UltraPure Yeast Beta Glucan (YBG®)

Immudyne’s Yeast Beta Glucan (YBG®)is purified from Baker’s Yeast; it is more than 95% pure and is tested for biological activity.

YBG is manufactured in a patented process proprietary to ImmuDyne Inc. at company facilities in Kentucky.

Scientific research on ImmuDyne’s Beta-1,3/1,6-D-Glucan purified yeast cell walls has been conducted by these renowned medical laboratories: Baylor College of Medicine, US Armed Forces Radiobiology Institute, Stanford University, Southwest Research Institute, Case Western Reserve University, the University of Arkansas, North Caroline State University, The University of Bern in Switzerland and the China Agricultural University, China.

The company continues research at various universities and institutions worldwide. ImmuDyne has developed an UltraPure Yeast Beta Glucan with unprecedented stability and reliability.

Unique characteristics of ImmuDyne´s UltraPure YBG®

1. UltraPure YBG® is the only particulate Yeast Beta Glucan product that can be delivered at a concentration of more than 95%

2. UltraPure YBG® is the only product on the market which can be delivered cleared of yeast by-products, endotoxin-free, and with a mannose protein content < 1%

3. UltraPure YBG® is the only yeast beta glucan that could demonstrate its product reliability (stability and biological response) over the last 10 years

4. UltraPure YBG® can be produced under GMP conditions

Advantages of UltraPure YBG®

UltraPure YBG® is the ideal candidate to proof the anticipated benefits to patients in clinical trials
UltraPure YBG® will become the optimal product for the consumer health care market space
UltraPure YBG® is the right choice for every development, marketing and distribution partner

Latest News